Clinical Trial Update: Canagliflozin in Patients With Acute Decompansted Heart Failure [Phase 3]

View source ↗

Summary

Phase 3 trial of canagliflozin in patients with acute decompensated heart failure has completed, with cohorts including chronic heart failure and diabetes melli…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Heart Failure

Drugs mentioned

• INVOKANA (CANAGLIFLOZIN)

Snippet

Sponsor: October 6 University | Conditions: Chronic Heart Failure, Acute Heart Failure | Phase 3 | Status: COMPLETED